Coronavirus Stocks

Below you will find a list of companies that have had the highest percentage gains and losses since coronavirus (COVID-19) became a major issue in the United States, which was approximately March 1st, 2020. Learn more.

CompanyYesterday's ClosePrice on March 1st, 2020Price ChangeConsensus RatingPrice TargetIndicator(s)
Extraction Oil & Gas logo
XOG
Extraction Oil & Gas
$56.49$0.70+7,957.3%Buy
MicroVision logo
MVIS
MicroVision
$19.56$0.25+7,594.7%HoldGap Down
Nabors Industries logo
NBR
Nabors Industries
$122.11$1.76+6,838.1%Sell$43.90
Oasis Petroleum logo
OAS
Oasis Petroleum
$101.26$1.64+6,093.3%Hold$18.06
GameStop logo
GME
GameStop
$200.37$3.60+5,465.8%Sell$21.40Gap Up
Axon Enterprise logo
AXON
Axon Enterprise
$158.76$2.93+5,318.4%Buy$176.80Gap Down
Cerevel Therapeutics logo
CERE
Cerevel Therapeutics
$13.78$0.40+3,371.0%Buy$21.50Gap Down
Marathon Digital logo
MARA
Marathon Digital
$27.83$0.86+3,137.2%Buy$48.50Analyst Report
Gap Down
Whiting Petroleum logo
WLL
Whiting Petroleum
$53.99$1.85+2,818.4%Buy$40.00
ContextLogic logo
WISH
ContextLogic
$13.50$0.47+2,803.2%Buy$22.92Insider Selling
Gap Up

One pot stock could skyrocket with looming interstate sales (Ad)

A new bill in Congress would decriminalize marijuana nationally by removing cannabis from the federal government’s list of controlled substances. The law would also allow one established Seattle cannabis company to market across state lines for the first time – potentially setting off a bidding war that could blast this stock into the stratosphere!

Find Out Why This Could Be the #1 Pot Stock
Callon Petroleum logo
CPE
Callon Petroleum
$53.82$2.27+2,270.9%Hold$24.60
Ares Acquisition logo
AAC
Ares Acquisition
$9.76$0.45+2,068.9%N/A
Blink Charging logo
BLNK
Blink Charging
$38.77$2.27+1,607.9%Buy$38.00
Ocugen logo
OCGN
Ocugen
$7.40$0.45+1,544.4%Hold$7.88
Cassava Sciences logo
SAVA
Cassava Sciences
$89.72$5.61+1,499.3%Buy$46.00News Coverage
Torchlight Energy Resources logo
TRCH
Torchlight Energy Resources
$9.92$0.65+1,423.8%N/AUpcoming Earnings
Unusual Options Activity
News Coverage
Gap Up
Danaos logo
DAC
Danaos
$72.78$5.04+1,344.0%Buy$44.42Analyst Revision
Overstock.com logo
OSTK
Overstock.com
$84.90$6.46+1,214.2%Buy$108.00
Futu logo
FUTU
Futu
$148.09$11.57+1,179.9%Buy$219.16
Celsius logo
CELH
Celsius
$67.46$5.91+1,041.5%Buy$55.00
Novavax logo
NVAX
Novavax
$180.99$16.00+1,031.2%Buy$225.50
NIO logo
NIO
NIO
$46.51$4.13+1,026.2%Buy$51.69
Digital Turbine logo
APPS
Digital Turbine
$67.72$6.13+1,004.7%Buy$82.50
Celldex Therapeutics logo
CLDX
Celldex Therapeutics
$28.25$2.63+974.1%Buy$35.50News Coverage
VMware logo
VMW
VMware
$157.34$15.00+948.9%Hold$174.62
C3.ai logo
AI
C3.ai
$57.89$5.66+922.8%Hold$107.22
Vuzix logo
VUZI
Vuzix
$16.12$1.58+920.3%Buy$21.50
Piedmont Lithium logo
PLL
Piedmont Lithium
$67.89$7.50+805.2%Buy$83.57
AMC Entertainment logo
AMC
AMC Entertainment
$55.69$6.26+789.6%Hold$4.71Insider Selling
Pacific Biosciences of California logo
PACB
Pacific Biosciences of California
$29.74$3.40+774.7%Buy$43.50
Antero Resources logo
AR
Antero Resources
$13.72$1.60+757.5%Buy$8.22
The Lovesac logo
LOVE
The Lovesac
$74.29$8.69+754.9%Buy$100.14Insider Selling
Caesars Entertainment logo
CZR
Caesars Entertainment
$103.82$12.71+716.8%Buy$103.60
Ideanomics logo
IDEX
Ideanomics
$2.92$0.36+710.0%Buy$7.00
Moderna logo
MRNA
Moderna
$208.24$25.93+703.1%Hold$162.44Insider Selling
GrowGeneration logo
GRWG
GrowGeneration
$41.12$5.53+643.6%Buy$56.25
eXp World logo
EXPI
eXp World
$35.34$4.78+639.3%Buy$62.00Insider Selling
Cambium Networks logo
CMBM
Cambium Networks
$46.04$6.25+636.6%Buy$45.38
At Home Group logo
HOME
At Home Group
$36.73$5.00+634.6%Hold$26.06
Bionano Genomics logo
BNGO
Bionano Genomics
$7.22$0.99+627.0%Buy$10.06
Fiverr International logo
FVRR
Fiverr International
$227.95$31.48+624.1%Buy$240.73
Seres Therapeutics logo
MCRB
Seres Therapeutics
$22.46$3.14+615.3%Buy$39.00News Coverage
Tupperware Brands logo
TUP
Tupperware Brands
$20.34$2.85+613.7%Buy$36.00News Coverage
Gap Up
Plug Power logo
PLUG
Plug Power
$29.85$4.34+587.8%Buy$46.59News Coverage
XPEL logo
XPEL
XPEL
$88.70$12.91+587.1%Buy$95.00Insider Selling
UP Fintech logo
TIGR
UP Fintech
$23.01$3.41+574.8%Buy$34.60
Silvergate Capital logo
SI
Silvergate Capital
$97.90$14.74+564.2%Buy$121.29
Jumia Technologies logo
JMIA
Jumia Technologies
$27.18$4.11+561.3%Hold$19.67
Anavex Life Sciences logo
AVXL
Anavex Life Sciences
$25.17$3.81+560.6%Buy$26.25Analyst Report
News Coverage
Gap Down
Owens & Minor logo
OMI
Owens & Minor
$44.94$6.83+558.0%Hold$35.44

One pot stock could skyrocket with looming interstate sales (Ad)

A new bill in Congress would decriminalize marijuana nationally by removing cannabis from the federal government’s list of controlled substances. The law would also allow one established Seattle cannabis company to market across state lines for the first time – potentially setting off a bidding war that could blast this stock into the stratosphere!

Find Out Why This Could Be the #1 Pot Stock
BioNTech logo
BNTX
BioNTech
$226.09$35.10+544.1%Hold$146.60
I-Mab logo
IMAB
I-Mab
$77.24$12.30+528.0%Buy$78.75
SEA logo
SE
SEA
$281.06$45.06+523.7%Buy$231.91
Vista Outdoor logo
VSTO
Vista Outdoor
$43.91$7.35+497.4%Buy$45.11
Intellia Therapeutics logo
NTLA
Intellia Therapeutics
$79.22$13.35+493.4%Buy$79.00Analyst Report
Gap Up
Upwork logo
UPWK
Upwork
$49.00$8.67+465.5%Buy$60.75
BioCryst Pharmaceuticals logo
BCRX
BioCryst Pharmaceuticals
$16.72$3.00+457.3%Buy$15.44
Protagonist Therapeutics logo
PTGX
Protagonist Therapeutics
$43.44$7.80+456.9%Buy$43.38
United Natural Foods logo
UNFI
United Natural Foods
$36.00$6.47+456.4%Hold$28.00
Gevo logo
GEVO
Gevo
$7.91$1.46+441.8%Buy$17.00
Fulgent Genetics logo
FLGT
Fulgent Genetics
$78.77$14.84+430.8%Hold$88.00
SiTime logo
SITM
SiTime
$120.03$22.66+429.7%Buy$120.40Analyst Upgrade
News Coverage
Range Resources logo
RRC
Range Resources
$14.66$2.77+429.2%Hold$11.39Analyst Downgrade
The Joint logo
JYNT
The Joint
$77.10$14.83+419.9%Buy$55.40
Lydall logo
LDL
Lydall
$61.72$11.91+418.2%Hold$26.00Unusual Options Activity
News Coverage
California Resources logo
CRC
California Resources
$32.75$6.35+415.7%Buy$40.00Insider Selling
Cerence logo
CRNC
Cerence
$111.12$21.71+411.8%Buy$120.10
Avid Technology logo
AVID
Avid Technology
$37.56$7.39+408.3%Buy$20.75
Amyris logo
AMRS
Amyris
$16.09$3.19+405.2%Buy$18.23
Clean Energy Fuels logo
CLNE
Clean Energy Fuels
$11.24$2.26+397.3%Buy$16.40
Calix logo
CALX
Calix
$44.15$9.00+390.6%Hold$35.33Analyst Report
Resolute Forest Products logo
RFP
Resolute Forest Products
$13.03$2.66+389.8%Buy$8.94Dividend Announcement
ShockWave Medical logo
SWAV
ShockWave Medical
$196.04$40.14+388.4%Buy$186.00
Party City Holdco logo
PRTY
Party City Holdco
$9.70$1.99+387.4%Buy$8.80News Coverage
360 DigiTech logo
QFIN
360 DigiTech
$40.43$8.36+383.6%Buy$31.33
Workhorse Group logo
WKHS
Workhorse Group
$14.54$3.02+382.3%Hold$20.50
Wayfair logo
W
Wayfair
$304.06$63.21+381.0%Hold$317.43
Cloudflare logo
NET
Cloudflare
$101.08$21.30+374.6%Buy$80.47
STAAR Surgical logo
STAA
STAAR Surgical
$148.16$31.38+372.1%Hold$84.25Insider Selling
News Coverage
Tesla logo
TSLA
Tesla
$620.83$132.87+367.3%Hold$458.56Insider Selling
Instil Bio logo
TIL
Instil Bio
$18.64$4.00+366.0%Buy$29.50News Coverage
Prothena logo
PRTA
Prothena
$49.41$10.66+363.5%Buy$47.38
SunOpta logo
STKL
SunOpta
$12.47$2.70+361.9%Buy$17.75
Sprout Social logo
SPT
Sprout Social
$90.36$19.65+359.8%Buy$73.30Analyst Downgrade
FuelCell Energy logo
FCEL
FuelCell Energy
$8.83$1.95+352.8%Hold$9.25
Farfetch logo
FTCH
Farfetch
$50.31$11.17+350.4%Buy$57.00
Snap logo
SNAP
Snap
$63.60$14.17+348.8%Buy$67.33Insider Selling
Daqo New Energy logo
DQ
Daqo New Energy
$58.70$13.11+347.6%Buy$90.42
Bilibili logo
BILI
Bilibili
$113.58$25.68+342.3%Buy$88.56
MicroStrategy logo
MSTR
MicroStrategy
$583.67$135.16+331.8%Hold$423.57Analyst Report
News Coverage
Gap Down
Textainer Group logo
TGH
Textainer Group
$35.24$8.25+327.2%Buy$30.00News Coverage
Organogenesis logo
ORGO
Organogenesis
$16.65$3.92+324.7%Buy$17.50
Scientific Games logo
SGMS
Scientific Games
$76.08$18.24+317.1%Hold$47.00
Zscaler logo
ZS
Zscaler
$216.41$51.95+316.6%Buy$211.56Insider Selling
Big Lots logo
BIG
Big Lots
$65.31$15.81+313.1%Hold$61.43
Endeavour Silver logo
EXK
Endeavour Silver
$6.43$1.56+312.2%Hold$6.62
Crocs logo
CROX
Crocs
$107.44$26.17+310.5%Buy$106.33
Peloton Interactive logo
PTON
Peloton Interactive
$108.11$26.69+305.1%Buy$140.97
Surgery Partners logo
SGRY
Surgery Partners
$66.45$16.42+304.7%Buy$32.07
Sorrento Therapeutics logo
SRNE
Sorrento Therapeutics
$8.69$2.17+300.5%Buy$30.33
CSV / Excel Export To export this table to CSV or Excel, upgrade to MarketBeat All Access.


(Ad)

A new bill in Congress would decriminalize marijuana nationally by removing cannabis from the federal government’s list of controlled substances. The law would also allow one established Seattle cannabis company to market across state lines for the first time – potentially setting off a bidding war that could blast this stock into the stratosphere!

The market contagion stemming from the spread of coronavirus has prompted companies to pre-emptively cut top and bottom-line forecasts citing supply chain disruptions and demand uncertainties. The S&P 500 (NYSEARCA: SPY) has descended into correction territory stoking fears of an impending bear market. The Federal Reserve implemented an emergency 50-basis point rate cut on March 2, 2020, to stave off coronavirus impact on the economy. Further rate cuts of at least another 50-basis points are anticipated in their meeting later this month. The yield on 10-year Treasuries sank to all-time lows below 0.7% bolstering fears of a global recession. Investors seeking portfolio protection during this tumultuous period of stock market uncertainty should take a closer look at these three stocks.

CoreLogic Inc. (NYSE: CLGX)

The dominant real estate, mortgage, and underwriting data analytics platform provider CoreLogic, Inc. (NYSE: CLGX)is a direct beneficiary of the spike in mortgage refi activity. Revenues grew six-percent YoY in their Q4 2019 earnings report beating consensus analyst EPS estimates by 0.07-per share coming in at 0.77-per share. Core mortgage and real estate solutions were the primary growth driver. This was prior to the coronavirus epidemic. Falling yields have materialized as a consequence of the economic turmoil unleashed by the spread of COVID-19. With the anticipation of more rate cuts to follow, mortgage lenders are experiencing a surge in mortgage refinancing activity. For example, a 15-year fixed rate of 3.12-percent just five years ago can be refinanced as a 10-year loan at 2.5-percent resulting in hundreds of dollars in monthly savings. While money center banks are seeing upticks on the mortgage side, that’s being offset by narrowing margins. For this reason, investors can sidestep the financials and consider the platform provider.

Utilizing the rifle charts, CLGX is one of the rare stocks with a double bullish monthly pup formation composed of a moving average (MA) pup breakout and a stochastic mini pup breakout. This is made possible by the resilient support on the rising 5-period MA at 45.48. The trajectory targets the upper monthly Bollinger Bands (BBs) at the 55.55 Fibonacci (fib) level.

Catasys (CATS)

In an era of healthcare cost-cutting initiatives, behavioral and mental health analytics, network and treatment platform provider Catasys, Inc. (NASDAQ: CATS) has a unique business model that optimizes efficiencies for insurers, providers and patients. Utilizing big data predictive analytics, CATS identifies health plan members that meet criteria for their proprietary OnTrak solution. CATS contracts with most of the nation’s largest health insurers to transition the most at risk and costliest patients who also suffer from behavioral, mental and/or substance abuse. Discreetly enrolling them in the 52-week OnTrak solution, patients utilize telemedicine and behavioral therapy to improve health as insurers see a 50-percent drop in healthcare costs, which CATS takes a percentage of. The model is designed to trim healthcare costs while improving patient care with the outcome and evidence-based treatment versus the traditional treatment center model which relies on higher healthcare costs from rising headcounts and longer “heads on beds” model. Revenues are improving but the company has yet to turn a profit. CATS is riding the healthcare cost efficiency and evidence-based treatment narrative which will continue to gain momentum, especially in an election year. CATS monthly chart has a potential monthly pup breakout which would target the 22.00 upper monthly BBs if the stochastic can cross back up.

Realty Income (O)  

Real estate investment trusts (REITs) tend to outperform benchmark indices during recessionary periods with stable dividends that can offset share depreciation. Realty Income (NYSE: O) is one of the most stable REITs with over 6,400 commercial properties throughout the U.S, U.K. and Puerto Rico. With a 98.6-percent occupancy rate, tenants include well-known household brands like Walgreens (NYSE: WBA) , Walmart (NYSE: WMT) , FedEx (NYSE: FDX) , 7-Eleven, Dollar Tree (NYSE: DLTR) and Dollar General (NYSE: DG). The company has distributed 595 consecutive months of dividends with 105 dividend increases since its NYSE listing in 1994. The company prides itself as a monthly dividend paying REIT currently yielding 3.70-percent on trailing 12-month basis. They also have a dividend reinvestment program (DRIP) for compounding gains and better dollar-cost averaging to take advantage of market downturns. Since O is a component of the SPY, there is a positive correlation with the trajectory of the benchmark S&P 500 index. Therefore, shares will still fall with the SPY. This one makes sense for investors with a long-term bullish outlook seeking steady monthly income at better than 10-year Treasury yields.

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.